Document Type

Article

Publication Date

April 2021

Patent Number

10975030

CPC

C07D 207/325, A61K 31/4025

Abstract

The present technology provides compounds according to Formula I or Formula III as well as compositions including such compounds useful for the treatment of metastatic cancer and/or glaucoma.

Application Number

16/346039

Assignees

University of Kansas

Filing Date

10/31/2017

Share

COinS